Insider filing · PHVS
Anne Lesage
Chief Early Development
profile →
Pharvaris N.V.
PHVS · Healthcare · 30 filings in 24 months
ticker →
Anne Lesage sold $2.6M of Pharvaris (PHVS)
Executed Jun 29, disclosed Jul 1, 2 days later.
Value, as filed
$2.6M
73,872 sh across 4 lots
Executed
Jun 29
the trade date, as filed
Disclosed
Jul 1
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ALAnne Lesage (Chief Early Development) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Pharvaris N.V. (PHVS). The largest single filing was $2.6M of PHVS (73,872 sh across 4 lots, as filed), executed Jun 29.
The name
PHVSHealthcare · Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases wit…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Anne Lesage in PHVS
PHVSSALE
Pharvaris N.V.
$765K20,000 sh × $38.27
Exec Sep 17
Filed Sep 21 · 3:13 PM ET PHVSSALE Pharvaris N.V. $1.1M
30,000 sh × $38.30
Exec Sep 10
Filed Sep 14 · 12:29 PM ET PHVSSALE Pharvaris N.V. $1.5M
48,300 sh across 5 lots
Exec Apr 29
Filed May 1 · 5:30 PM ET PHVSSALE Pharvaris N.V. $421K
14,000 sh across 2 lots
Exec Apr 22
Filed Apr 24 · 5:30 PM ET